Millennium Management’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
ECM
Millennium Management's OCRX Position: Q1 2017 in Review
Millennium Management sold out of Ocera Therapeutics (OCRX) in Q1 2017, closing a stake of 320,000 shares — an estimated $672K sold.
Millennium Management first reported a position in OCRX in Q1 2014 and held it in 12 quarters. The position peaked at $4.25M in Q1 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.
- Millennium Management reported no remaining Ocera Therapeutics position as of Q1 2017 after selling out during the quarter.
- Millennium Management sold 320,000 Ocera Therapeutics shares in Q1 2017, an estimated $672K.
- Millennium Management first reported a position in Ocera Therapeutics in Q1 2014 and held it in 12 quarters.
- Millennium Management's Ocera Therapeutics position peaked at $4.25M in Q1 2014.
- 26 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q1 2017.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.